PUMA BIOTECHNOLOGY INC (PBYI) Stock Earnings & Estimates
USA - NASDAQ:PBYI - US74587V1070 - Common Stock
5.19 USD
+0.46 (+9.73%)
5.18 USD
-0.01 (-0.19%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 228M -9.95% | 235.637M 3.35% | 230.468M -2.19% | 220.83M -4.18% | 211.14M -4.39% | 209.61M -0.72% | 218.28M 4.14% | 216.24M -0.93% | 214.2M -0.94% | |
| EBITDA YoY % growth | 32.72M 174.96% | 44.784M 36.87% | 42.49M -5.12% | 37.74M -11.18% | 23.46M -37.84% | 31.62M 34.78% | N/A | N/A | N/A | |
| EBIT YoY % growth | 23.8M 1,730.77% | 33.265M 39.77% | 30.966M -6.91% | 29.325M -5.30% | 20.145M -31.30% | 21.42M 6.33% | 16.83M -21.43% | 9.18M -45.45% | 510K -94.44% | |
| Operating Margin | 10.44% | 14.12% | 13.44% | 13.28% | 9.54% | 10.22% | 7.71% | 4.25% | 0.24% | |
| EPS YoY % growth | 0.00 100.00% | 0.46 3,314,649,325,744,685,000.00% | 0.61 32.61% | 0.50 -17.31% | 0.33 -34.68% | 0.35 5.26% | 0.46 32.35% | 0.31 -33.33% | 0.15 -50.00% |
All data in USD
| Q4 / 25 | Q1 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 0.22 -44.82% | 0.04 -30.30% |
| Revenue Q2Q % growth | 69.972M 18.40% | 49.98M 8.65% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | 18.666M 39.66% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.17 -58.54% | 0.05 | 0.12 | 270.37% |
| Q2 2025 Q2Q % growth | 0.12 233.33% | 0.10 | 0.02 | 14.59% |
| Q1 2025 Q2Q % growth | 0.06 160.00% | -0.02 | 0.08 | 394.12% |
| Q4 2024 Q2Q % growth | 0.39 50.00% | 0.10 | 0.29 | 272.41% |
| Q3 2024 Q2Q % growth | 0.41 241.67% | 0.36 | 0.05 | 14.63% |
| Q2 2024 Q2Q % growth | -0.09 -280.00% | -0.13 | 0.04 | 31.95% |
| Q1 2024 Q2Q % growth | -0.10 -433.33% | -0.22 | 0.12 | 54.75% |
| Q4 2023 Q2Q % growth | 0.26 316.67% | 0.31 | -0.05 | -14.94% |
| Q3 2023 Q2Q % growth | 0.12 1,300.00% | 0.08 | 0.04 | 53.45% |
| Q2 2023 Q2Q % growth | 0.05 -76.19% | 0.01 | 0.04 | 553.59% |
| Q1 2023 Q2Q % growth | 0.03 137.50% | -0.07 | 0.10 | 142.02% |
| Q4 2022 Q2Q % growth | -0.12 -220.00% | 0.05 | -0.17 | -335.29% |
| Q3 2022 Q2Q % growth | -0.01 98.89% | -0.06 | 0.05 | 82.17% |
| Q2 2022 Q2Q % growth | 0.21 261.54% | 0.01 | 0.20 | 1,918.45% |
| Q1 2022 Q2Q % growth | -0.08 -120.00% | -0.17 | 0.09 | 52.75% |
| Q4 2021 Q2Q % growth | 0.10 126.32% | -0.09 | 0.19 | 211.92% |
| Q3 2021 Q2Q % growth | -0.90 -13.92% | -0.32 | -0.58 | -183.10% |
| Q2 2021 Q2Q % growth | -0.13 -262.50% | -0.28 | 0.15 | 53.02% |
| Q1 2021 Q2Q % growth | 0.40 193.02% | 0.09 | 0.31 | 350.76% |
| Q4 2020 Q2Q % growth | -0.38 -31.03% | -0.32 | -0.06 | -19.32% |
| Q3 2020 Q2Q % growth | -0.79 -79.55% | -0.40 | -0.39 | -96.13% |
| Q2 2020 Q2Q % growth | 0.08 108.25% | -0.30 | 0.38 | 126.33% |
| Q1 2020 Q2Q % growth | -0.43 -65.38% | -0.79 | 0.36 | 45.40% |
| Q4 2019 Q2Q % growth | -0.29 | -0.49 | 0.20 | 41.38% |
| Q3 2019 Q2Q % growth | -0.44 | -0.72 | 0.28 | 39.15% |
| Q2 2019 Q2Q % growth | -0.97 | -0.96 | -0.01 | -0.53% |
| Q1 2019 Q2Q % growth | -0.26 | -0.70 | 0.44 | 62.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 54.5M -32.30% | 52.02M | 2.48M | 4.77% |
| Q2 2025 Q2Q % growth | 52.4M 11.25% | 51.765M | 635K | 1.23% |
| Q1 2025 Q2Q % growth | 46M 5.02% | 45.441M | 559K | 1.23% |
| Q4 2024 Q2Q % growth | 59.1M -18.14% | 53.55M | 5.55M | 10.36% |
| Q3 2024 Q2Q % growth | 80.5M 43.49% | 72.063M | 8.437M | 11.71% |
| Q2 2024 Q2Q % growth | 47.1M -13.74% | 45.594M | 1.506M | 3.30% |
| Q1 2024 Q2Q % growth | 43.8M -17.01% | 41.871M | 1.929M | 4.61% |
| Q4 2023 Q2Q % growth | 72.2M 9.93% | 75.021M | -2.821M | -3.76% |
| Q3 2023 Q2Q % growth | 56.1M -1.75% | 59.109M | -3.009M | -5.09% |
| Q2 2023 Q2Q % growth | 54.6M -8.27% | 52.768M | 1.832M | 3.47% |
| Q1 2023 Q2Q % growth | 52.775M 15.38% | 50.626M | 2.149M | 4.24% |
| Q4 2022 Q2Q % growth | 65.68M 18.64% | 58.205M | 7.475M | 12.84% |
| Q3 2022 Q2Q % growth | 57.1M 23.46% | 51.476M | 5.624M | 10.93% |
| Q2 2022 Q2Q % growth | 59.52M 11.50% | 53.676M | 5.844M | 10.89% |
| Q1 2022 Q2Q % growth | 45.74M -53.41% | 45.968M | -228K | -0.50% |
| Q4 2021 Q2Q % growth | 55.36M 5.33% | 48.11M | 7.25M | 15.07% |
| Q3 2021 Q2Q % growth | 46.25M -8.87% | 54.378M | -8.128M | -14.95% |
| Q2 2021 Q2Q % growth | 53.38M -24.37% | 54.058M | -678K | -1.25% |
| Q1 2021 Q2Q % growth | 98.17M 91.66% | 72.898M | 25.272M | 34.67% |
| Q4 2020 Q2Q % growth | 52.56M -16.47% | 53.848M | -1.288M | -2.39% |
| Q3 2020 Q2Q % growth | 50.75M -9.94% | 54.11M | -3.36M | -6.21% |
| Q2 2020 Q2Q % growth | 70.58M 30.90% | 59.373M | 11.207M | 18.88% |
| Q1 2020 Q2Q % growth | 51.22M -48.30% | 45.826M | 5.394M | 11.77% |
| Q4 2019 Q2Q % growth | 62.92M | 61.157M | 1.763M | 2.88% |
| Q3 2019 Q2Q % growth | 56.35M | 61.606M | -5.256M | -8.53% |
| Q2 2019 Q2Q % growth | 53.92M | 54.035M | -115K | -0.21% |
| Q1 2019 Q2Q % growth | 99.07M | 68.592M | 30.478M | 44.43% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -59.09% | 0% | 4.47% |
| Revenue | 0% | -15% | 0% | -0.6% |